Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
治疗小儿急性上呼吸道感染(感冒风热证)发热有效性和安全性的安慰剂对照、多中心Ⅱa期临床研究。
[Translation] A placebo-controlled, multicenter phase IIa clinical study on the effectiveness and safety of treating fever caused by acute upper respiratory tract infection (cold-wind-heat syndrome) in children.
1.探索柴芩小儿清热栓治疗小儿急性上呼吸道感染(感冒风热证)发热的退热作用; 2.观察柴芩小儿清热栓临床应用的安全性
[Translation] 1. To explore the antipyretic effect of Chaiqin Children's Qingre Suppository in treating fever caused by acute upper respiratory tract infection (cold wind-heat syndrome) in children; 2. To observe the safety of Chaiqin Children's Qingre Suppository in clinical application
100 Clinical Results associated with Shenzhen Beikelian Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shenzhen Beikelian Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shenzhen Beikelian Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shenzhen Beikelian Pharmaceutical Technology Co., Ltd.